SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of
1934
Date
of Report (Date of earliest event reported) : April
2, 2008
|
|
SAFESTITCH
MEDICAL, INC.
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
Delaware
|
|
0-19437
|
|
11-2962080
|
(State
or Other Jurisdiction of
Incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
4400
Biscayne Boulevard
Suite 670
Miami,
Florida 33137
|
(Address
of Principal Executive Office)
|
|
(305) 575-6000
|
Registrant’s
telephone number, including area code
|
|
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
|
|
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item
5.02 |
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
(b) On
April
2, 2008, Kenneth Block resigned as Chief Financial Officer of SafeStitch
Medical, Inc. (the “Company”).
(c) On
April
3, 2008, Adam S. Jackson was appointed Chief Financial Officer of the Company,
having joined the Company as Vice President, Finance on March 24, 2008.
Mr.
Jackson, who is 45 years old, served as Senior Vice President, Finance
for
Levitt Corporation (“Levitt”), a publicly-traded real estate development
company, from 2006 to 2008, where he was responsible for the Levitt’s financial
planning and analysis activities. From 2003 to 2006, Mr. Jackson served
as
Levitt’s Senior Vice President, Controller, during which period he supervised
Levitt’s accounting and financial reporting activities. In this capacity, Mr.
Jackson oversaw the preparation and filing of Levitt’s registration statements
and periodic reports with the Securities Exchange Commission, and presided
over
the company’s initial evaluation of internal control over financial reporting in
accordance with the Sarbanes-Oxley Act of 2002. From 2001 to 2003, Mr.
Jackson
served as Chief Financial Officer of Romika-USA, Inc., a privately held
consumer
goods manufacturing and distribution company. From 2000 to 2001, Mr. Jackson
served as Chief Operating Officer of V-Commex.com Corp., a privately-held
internet company developing an international business-to-business web portal.
From 1998 to 2000, Mr. Jackson served as Director of Financial Planning
and
Analysis at Eclipsys Corporation, a publicly-traded healthcare information
technology provider.
Other
than as described in this Current Report on Form 8-K, there are no arrangements
or understandings between Mr. Jackson and any other person pursuant to
which Mr.
Jackson was selected as an officer, other than the Company’s compensation
arrangements and plans for executive officers and the Company’s other policies
and procedures which are generally applicable to executive
officers.
Since
the
beginning of the Company’s last fiscal year, the Company has not been a
participant in any transactions within the meaning of Item 404(a) of Regulation
S-K, and there are no such proposed transactions, or series of similar
transactions, in which Mr. Jackson had a direct or indirect material interest.
Mr.
Jackson’s employment with the Company is governed by an offer letter, dated
March 11, 2008, and executed on March 14, 2008 (the “Agreement”). Pursuant to
the Agreement, Mr. Jackson will receive an initial annual base salary of
$170,000, subject to adjustment in accordance with the Company’s employee
compensation policies. Additionally, Mr. Jackson is eligible to receive
a
discretionary, performance-based bonus, payable in cash, stock options
or a
combination thereof. Mr. Jackson’s employment with the Company is “at will”,
which means that either he or the Company may terminate his employment
at any
time and for any reason, with or without cause.
In
accordance with the Agreement, on March, 24, 2008, the Company granted
to Mr.
Jackson an option (the “Option”) to purchase 50,000 shares of the Company’s
common stock at an exercise price of $3.00 per share, which was the fair
market
value of our common stock on such date. The Option vests equally twenty-five
percent (25%) per year on the first four anniversaries of the grant date.
Mr.
Jackson will also be entitled to participate in such benefit programs as
are
generally made available to other employees of the Company, as well as
reimbursement for COBRA premiums to maintain Mr. Jackson’s medical and dental
insurance with his previous employer until December 31, 2008, with such
reimbursement limited to the amount the Company contributes to similarly
situated employees. In addition to his duties with the Company, it is
anticipated that Mr. Jackson will provide financial and accounting services
for
certain other private or public companies as may be designated by the Company.
Mr. Jackson will not receive any additional base salary for these services,
but
the Company may receive compensation from those other companies to which
Mr.
Jackson provides services.
The
foregoing description of the Agreement is not complete and is qualified
in its
entirety by the Agreement, which is attached as Exhibit 10.1 to this Current
Report on Form 8-K and is incorporated by reference herein
(e) The
description of the Agreement contained in Item 5.02(c) to this Current
Report on
Form 8-K is hereby incorporated by reference in this Item 5.02(e).
Item
9.01. |
Financial
Statements and Exhibits
|
(d) Exhibits.
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.1
|
|
Offer
Letter from SafeStitch Medical, Inc. to Adam S. Jackson,
dated March 11,
2008
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
SAFESTITCH
MEDICAL, INC.
|
Date:
April 3, 2008
|
By:
|
/s/
Jeffrey G. Spragens
|
|
|
Jeffrey
G. Spragens
|
|
|
Chief
Executive Officer and
President
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.1
|
|
Offer
Letter from SafeStitch Medical, Inc. to Adam S. Jackson, dated March
11,
2008
|
SafeStitch
Medical, Inc.
4400
Biscayne Boulevard
Suite
670
Miami,
Florida 33137
March
11,
2008
RE:
Letter Agreement, Terms of Employment
Adam
S.
Jackson
768
West
51st
Street
Miami
Beach, FL 33140
Dear
Adam:
On
behalf
of SafeStitch Medical, Inc. (the "Company"), I am pleased to confirm our offer
of employment to you in the capacity of Vice President, Finance. We are
confident that you will be an excellent addition to the Company and provide
significant influence in achieving our goals. This employment letter sets forth
the terms and conditions.
1. Position.
You
are
being offered to serve in a full-time capacity as Vice President, Finance.
You
will report directly to the President and CEO.
2. Salary.
You will
be paid a salary at the annual rate of $ 170,000.00, payable in monthly
installments in accordance with the Company’s prevailing payroll practices for
salaried employees. This salary will be subject to adjustment pursuant to the
Company’s employee compensation policies in effect from time to time. All forms
of compensation referred to in this letter are subject to reduction to reflect
applicable withholding and payroll taxes.
3. Bonus.
You
will
be eligible for a discretionary yearly bonus, based on performance, in the
form
of additional cash compensation and/or stock options, in accordance with the
procedures established by the Company for management.
4. Stock
Options.
Subject
to the approval of the Company’s Board of Directors, you will be granted an
option to purchase fifty thousand (50,000) shares of the Company’s common stock.
The exercise price per share will be equal to the fair market value per share
on
the date the option is granted or on your first day of employment, whichever
is
later. The options will be subject to the terms and conditions contained in
a
stock option agreement to be entered into by you and the Company prior to the
grant. The options will vest equally 25% per year on the first four
anniversaries of the grant date as described in your stock option
agreement.
5. Benefits.
You
will
be entitled to participate in such benefit programs as are generally made
available to other employees of the Company. Current benefit programs include
medical, dental, vision care, life insurance, long term disability, short term
disability and life insurance. You will be able to enroll in the 401k program
in
the near future. We will reimburse your monthly COBRA payments for Medical
and
Dental insurance up to what the company normally contributes towards insurance
for similarly situated employees, for 9 months until December 31,
2008.
6. Vacation.
You will
be entitled to three weeks paid vacation each year, nine scheduled and three
floating holidays and in accordance with the Company’s then prevailing policies
for salaried employees. Vacation is prorated based on start date of
employee.
7. Prior
Employment.
By
accepting the terms of this agreement, you are representing and warranting
to
the Company that you are under no contractual commitments inconsistent with
your
proposed obligations to the Company. You are also representing and warranting
to
the company the accuracy of the contents of your resume. Any breach of this
representation will result in the termination of your employment.
8. Period
of Employment. Your
employment with the Company will be “at will,” meaning that either you or the
Company will be entitled to terminate your employment at any time and for any
reason, with or without cause. This is the full and complete agreement between
you and the Company on this term. Although your job duties, title, compensation
and benefits, as well as the Company’s personnel policies and procedures, may
change from time to time, the “at will” nature of your employment may only be
changed in an express written agreement signed by you and a duly authorized
officer of the Company.
9. Outside
Activities.
While
you render services to the Company, you will not engage in any other gainful
employment, business or activity without the written consent of the Company.
Nevertheless, the company and you agree that you will be providing services
to
one or more other private or public companies as designated by the company,
at
no additional compensation. While you render services to the Company, you also
will not assist any person or organization in competing with the Company, in
preparing to compete with the Company or in hiring any employees of the Company.
10. Amendment
and Governing Law.
This
letter agreement may not be amended or modified except by an express written
agreement signed by you and a duly authorized officer of the Company. The terms
of this letter agreement and the resolution of any disputes will be governed
by
the laws of the State of Florida.
This
letter contains all of the terms of your employment with the Company and
supersedes any prior understandings or agreements, whether oral or written,
between you and the Company.
We
hope
that you find the foregoing terms acceptable and look forward to working with
you. You may indicate your agreement with these terms and accept this offer
by
signing and dating both the enclosed duplicate original of this letter and
returning it to me. As required by law, your employment with the Company is
also
contingent upon your providing legal proof of your identity and authorization
to
work in the United States. Under Federal law, every employee must sign a Form
I-9 and present proper proof of his or her right to work in the United
States.
This
offer, if not accepted, will expire at the close of business (EDT) on March
14,
2008. We look forward to having you join us on March 24, 2008. If you have
any
questions, please call me at 305 575-4145.
|
Sincerely,
/s/
Stewart B. Davis M.D.
Stewart
B. Davis M.D.
Chief
Operating Officer
SafeStitch
Medical, Inc.
|
I
agree
to the foregoing terms of employment:
/s/
Adam S. Jackson
Adam
S.
Jackson